APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV Therapy Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global HIV Therapy Drug Market Analysis and Forecast 2026-2032

30 December 2025217 pages

Choose your research edition.

Industry ResearchHIV Therapy Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Therapy Drug Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal HIV Therapy Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Therapy Drug Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Therapy Drug Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global HIV Therapy Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HIV Therapy Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for HIV Therapy Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for HIV Therapy Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for HIV Therapy Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of HIV Therapy Drug include AbbVie Inc., Affine Formulations Limited, Beacon Pharmaceuticals, Biocon Limited, Boehringer Ingelheim, Bristol-Myers Squibb Company, Cipla, Frontier Biotechnologies and Genentech, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for HIV Therapy Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HIV Therapy Drug, also provides the sales of main regions and countries. Of the upcoming market potential for HIV Therapy Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HIV Therapy Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HIV Therapy Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for HIV Therapy Drug sales, projected growth trends, production technology, application and end-user industry.

HIV Therapy Drug Segment by Company

AbbVie Inc.

Affine Formulations Limited

Beacon Pharmaceuticals

Biocon Limited

Boehringer Ingelheim

Bristol-Myers Squibb Company

Cipla

Frontier Biotechnologies

Genentech, Inc.

Gilead Sciences, Inc

IPCA Laboratories

Janssen Pharmaceuticals, Inc.

Julphar Bangladesh

Merck & Co

MSD

Mylan Pharmaceuticals Inc.

Natco Pharma

Roche Holding AG

Shionogi

Theratechnologies Inc.

ViiV Healthcare

GSK

Pfizer

Johnson & Johnson

Teva Pharmaceuticals

Abbott

HIV Therapy Drug Segment by Type

Hiv Integrated Enzyme Chain Transfer Inhibitor

Multi-Type Combined Drugs

Non-Nucleoside Reverse Transcription Enzyme Inhibitors

Nucleoside Reverse Transcription Enzyme Inhibitors

HIV Therapy Drug Segment by Application

Hospital

Clinic

Pharmacy

HIV Therapy Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Therapy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Therapy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Therapy Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of HIV Therapy Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of HIV Therapy Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Therapy Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HIV Therapy Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hiv Integrated Enzyme Chain Transfer Inhibitor Major Manufacturers Table 3. Multi-Type Combined Drugs Major Manufacturers Table 4. Non-Nucleoside Reverse Transcription Enzyme Inhibitors Major Manufacturers Table 5. Nucleoside Reverse Transcription Enzyme Inhibitors Major Manufacturers Table 6. Global HIV Therapy Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Pharmacy Major Manufacturers Table 10. HIV Therapy Drug Industry Trends Table 11. HIV Therapy Drug Industry Drivers Table 12. HIV Therapy Drug Industry Opportunities and Challenges Table 13. HIV Therapy Drug Industry Restraints Table 14. Global HIV Therapy Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global HIV Therapy Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global HIV Therapy Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global HIV Therapy Drug Revenue Market Share by Region (2021-2026) Table 18. Global HIV Therapy Drug Revenue Market Share by Region (2027-2032) Table 19. Global HIV Therapy Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global HIV Therapy Drug Sales by Region (2021-2026) & (K Units) Table 21. Global HIV Therapy Drug Sales by Region (2027-2032) & (K Units) Table 22. Global HIV Therapy Drug Sales Market Share by Region (2021-2026) Table 23. Global HIV Therapy Drug Sales Market Share by Region (2027-2032) Table 24. Global HIV Therapy Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global HIV Therapy Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global HIV Therapy Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global HIV Therapy Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global HIV Therapy Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global HIV Therapy Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global HIV Therapy Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global HIV Therapy Drug Manufacturers, Product Type & Application Table 32. Global HIV Therapy Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global HIV Therapy Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global HIV Therapy Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global HIV Therapy Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global HIV Therapy Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global HIV Therapy Drug Revenue Market Share by Type (2021-2026) Table 39. Global HIV Therapy Drug Revenue Market Share by Type (2027-2032) Table 40. Global HIV Therapy Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 42. Global HIV Therapy Drug Sales by Type (2027-2032) & (K Units) Table 43. Global HIV Therapy Drug Sales Market Share by Type (2021-2026) Table 44. Global HIV Therapy Drug Sales Market Share by Type (2027-2032) Table 45. Global HIV Therapy Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global HIV Therapy Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global HIV Therapy Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global HIV Therapy Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global HIV Therapy Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global HIV Therapy Drug Revenue Market Share by Application (2021-2026) Table 51. Global HIV Therapy Drug Revenue Market Share by Application (2027-2032) Table 52. Global HIV Therapy Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 54. Global HIV Therapy Drug Sales by Application (2027-2032) & (K Units) Table 55. Global HIV Therapy Drug Sales Market Share by Application (2021-2026) Table 56. Global HIV Therapy Drug Sales Market Share by Application (2027-2032) Table 57. Global HIV Therapy Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global HIV Therapy Drug Price by Application (2027-2032) & (US$/Unit) Table 59. AbbVie Inc. Company Information Table 60. AbbVie Inc. Business Overview Table 61. AbbVie Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. AbbVie Inc. HIV Therapy Drug Product Portfolio Table 63. AbbVie Inc. Recent Development Table 64. Affine Formulations Limited Company Information Table 65. Affine Formulations Limited Business Overview Table 66. Affine Formulations Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Affine Formulations Limited HIV Therapy Drug Product Portfolio Table 68. Affine Formulations Limited Recent Development Table 69. Beacon Pharmaceuticals Company Information Table 70. Beacon Pharmaceuticals Business Overview Table 71. Beacon Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Beacon Pharmaceuticals HIV Therapy Drug Product Portfolio Table 73. Beacon Pharmaceuticals Recent Development Table 74. Biocon Limited Company Information Table 75. Biocon Limited Business Overview Table 76. Biocon Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Biocon Limited HIV Therapy Drug Product Portfolio Table 78. Biocon Limited Recent Development Table 79. Boehringer Ingelheim Company Information Table 80. Boehringer Ingelheim Business Overview Table 81. Boehringer Ingelheim HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Boehringer Ingelheim HIV Therapy Drug Product Portfolio Table 83. Boehringer Ingelheim Recent Development Table 84. Bristol-Myers Squibb Company Company Information Table 85. Bristol-Myers Squibb Company Business Overview Table 86. Bristol-Myers Squibb Company HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bristol-Myers Squibb Company HIV Therapy Drug Product Portfolio Table 88. Bristol-Myers Squibb Company Recent Development Table 89. Cipla Company Information Table 90. Cipla Business Overview Table 91. Cipla HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Cipla HIV Therapy Drug Product Portfolio Table 93. Cipla Recent Development Table 94. Frontier Biotechnologies Company Information Table 95. Frontier Biotechnologies Business Overview Table 96. Frontier Biotechnologies HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Frontier Biotechnologies HIV Therapy Drug Product Portfolio Table 98. Frontier Biotechnologies Recent Development Table 99. Genentech, Inc. Company Information Table 100. Genentech, Inc. Business Overview Table 101. Genentech, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Genentech, Inc. HIV Therapy Drug Product Portfolio Table 103. Genentech, Inc. Recent Development Table 104. Gilead Sciences, Inc Company Information Table 105. Gilead Sciences, Inc Business Overview Table 106. Gilead Sciences, Inc HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Gilead Sciences, Inc HIV Therapy Drug Product Portfolio Table 108. Gilead Sciences, Inc Recent Development Table 109. IPCA Laboratories Company Information Table 110. IPCA Laboratories Business Overview Table 111. IPCA Laboratories HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. IPCA Laboratories HIV Therapy Drug Product Portfolio Table 113. IPCA Laboratories Recent Development Table 114. Janssen Pharmaceuticals, Inc. Company Information Table 115. Janssen Pharmaceuticals, Inc. Business Overview Table 116. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product Portfolio Table 118. Janssen Pharmaceuticals, Inc. Recent Development Table 119. Julphar Bangladesh Company Information Table 120. Julphar Bangladesh Business Overview Table 121. Julphar Bangladesh HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Julphar Bangladesh HIV Therapy Drug Product Portfolio Table 123. Julphar Bangladesh Recent Development Table 124. Merck & Co Company Information Table 125. Merck & Co Business Overview Table 126. Merck & Co HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Merck & Co HIV Therapy Drug Product Portfolio Table 128. Merck & Co Recent Development Table 129. MSD Company Information Table 130. MSD Business Overview Table 131. MSD HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. MSD HIV Therapy Drug Product Portfolio Table 133. MSD Recent Development Table 134. Mylan Pharmaceuticals Inc. Company Information Table 135. Mylan Pharmaceuticals Inc. Business Overview Table 136. Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Mylan Pharmaceuticals Inc. HIV Therapy Drug Product Portfolio Table 138. Mylan Pharmaceuticals Inc. Recent Development Table 139. Natco Pharma Company Information Table 140. Natco Pharma Business Overview Table 141. Natco Pharma HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Natco Pharma HIV Therapy Drug Product Portfolio Table 143. Natco Pharma Recent Development Table 144. Roche Holding AG Company Information Table 145. Roche Holding AG Business Overview Table 146. Roche Holding AG HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Roche Holding AG HIV Therapy Drug Product Portfolio Table 148. Roche Holding AG Recent Development Table 149. Shionogi Company Information Table 150. Shionogi Business Overview Table 151. Shionogi HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Shionogi HIV Therapy Drug Product Portfolio Table 153. Shionogi Recent Development Table 154. Theratechnologies Inc. Company Information Table 155. Theratechnologies Inc. Business Overview Table 156. Theratechnologies Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Theratechnologies Inc. HIV Therapy Drug Product Portfolio Table 158. Theratechnologies Inc. Recent Development Table 159. ViiV Healthcare Company Information Table 160. ViiV Healthcare Business Overview Table 161. ViiV Healthcare HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. ViiV Healthcare HIV Therapy Drug Product Portfolio Table 163. ViiV Healthcare Recent Development Table 164. GSK Company Information Table 165. GSK Business Overview Table 166. GSK HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. GSK HIV Therapy Drug Product Portfolio Table 168. GSK Recent Development Table 169. Pfizer Company Information Table 170. Pfizer Business Overview Table 171. Pfizer HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Pfizer HIV Therapy Drug Product Portfolio Table 173. Pfizer Recent Development Table 174. Johnson & Johnson Company Information Table 175. Johnson & Johnson Business Overview Table 176. Johnson & Johnson HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Johnson & Johnson HIV Therapy Drug Product Portfolio Table 178. Johnson & Johnson Recent Development Table 179. Teva Pharmaceuticals Company Information Table 180. Teva Pharmaceuticals Business Overview Table 181. Teva Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Teva Pharmaceuticals HIV Therapy Drug Product Portfolio Table 183. Teva Pharmaceuticals Recent Development Table 184. Abbott Company Information Table 185. Abbott Business Overview Table 186. Abbott HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. Abbott HIV Therapy Drug Product Portfolio Table 188. Abbott Recent Development Table 189. North America HIV Therapy Drug Revenue by Type (2021-2026) & (US$ Million) Table 190. North America HIV Therapy Drug Revenue by Type (2027-2032) & (US$ Million) Table 191. North America HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 192. North America HIV Therapy Drug Sales by Type (2027-2032) & (K Units) Table 193. North America HIV Therapy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 194. North America HIV Therapy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 195. North America HIV Therapy Drug Revenue by Application (2021-2026) & (US$ Million) Table 196. North America HIV Therapy Drug Revenue by Application (2027-2032) & (US$ Million) Table 197. North America HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 198. North America HIV Therapy Drug Sales by Application (2027-2032) & (K Units) Table 199. North America HIV Therapy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 200. North America HIV Therapy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 201. North America HIV Therapy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. North America HIV Therapy Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. North America HIV Therapy Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. North America HIV Therapy Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 205. North America HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 206. North America HIV Therapy Drug Sales by Country (2027-2032) & (K Units) Table 207. North America HIV Therapy Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 208. North America HIV Therapy Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 209. United States HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 210. Canada HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 211. Europe HIV Therapy Drug Revenue by Type (2021-2026) & (US$ Million) Table 212. Europe HIV Therapy Drug Revenue by Type (2027-2032) & (US$ Million) Table 213. Europe HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 214. Europe HIV Therapy Drug Sales by Type (2027-2032) & (K Units) Table 215. Europe HIV Therapy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 216. Europe HIV Therapy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 217. Europe HIV Therapy Drug Revenue by Application (2021-2026) & (US$ Million) Table 218. Europe HIV Therapy Drug Revenue by Application (2027-2032) & (US$ Million) Table 219. Europe HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 220. Europe HIV Therapy Drug Sales by Application (2027-2032) & (K Units) Table 221. Europe HIV Therapy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 222. Europe HIV Therapy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 223. Europe HIV Therapy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 224. Europe HIV Therapy Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 225. Europe HIV Therapy Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 226. Europe HIV Therapy Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 227. Europe HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 228. Europe HIV Therapy Drug Sales by Country (2027-2032) & (K Units) Table 229. Europe HIV Therapy Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 230. Europe HIV Therapy Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 231. Germany HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 232. France HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 233. U.K. HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 234. Italy HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 235. Netherlands HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 236. China HIV Therapy Drug Revenue by Type (2021-2026) & (US$ Million) Table 237. China HIV Therapy Drug Revenue by Type (2027-2032) & (US$ Million) Table 238. China HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 239. China HIV Therapy Drug Sales by Type (2027-2032) & (K Units) Table 240. China HIV Therapy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 241. China HIV Therapy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 242. China HIV Therapy Drug Revenue by Application (2021-2026) & (US$ Million) Table 243. China HIV Therapy Drug Revenue by Application (2027-2032) & (US$ Million) Table 244. China HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 245. China HIV Therapy Drug Sales by Application (2027-2032) & (K Units) Table 246. China HIV Therapy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 247. China HIV Therapy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 248. Asia HIV Therapy Drug Revenue by Type (2021-2026) & (US$ Million) Table 249. Asia HIV Therapy Drug Revenue by Type (2027-2032) & (US$ Million) Table 250. Asia HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 251. Asia HIV Therapy Drug Sales by Type (2027-2032) & (K Units) Table 252. Asia HIV Therapy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 253. Asia HIV Therapy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 254. Asia HIV Therapy Drug Revenue by Application (2021-2026) & (US$ Million) Table 255. Asia HIV Therapy Drug Revenue by Application (2027-2032) & (US$ Million) Table 256. Asia HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 257. Asia HIV Therapy Drug Sales by Application (2027-2032) & (K Units) Table 258. Asia HIV Therapy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 259. Asia HIV Therapy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 260. Asia HIV Therapy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 261. Asia HIV Therapy Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 262. Asia HIV Therapy Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 263. Asia HIV Therapy Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 264. Asia HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 265. Asia HIV Therapy Drug Sales by Country (2027-2032) & (K Units) Table 266. Asia HIV Therapy Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 267. Asia HIV Therapy Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 268. Japan HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 269. South Korea HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 270. India HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 271. Australia HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 272. China Taiwan HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 273. Southeast Asia HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 274. SAMEA HIV Therapy Drug Revenue by Type (2021-2026) & (US$ Million) Table 275. SAMEA HIV Therapy Drug Revenue by Type (2027-2032) & (US$ Million) Table 276. SAMEA HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 277. SAMEA HIV Therapy Drug Sales by Type (2027-2032) & (K Units) Table 278. SAMEA HIV Therapy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 279. SAMEA HIV Therapy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 280. SAMEA HIV Therapy Drug Revenue by Application (2021-2026) & (US$ Million) Table 281. SAMEA HIV Therapy Drug Revenue by Application (2027-2032) & (US$ Million) Table 282. SAMEA HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 283. SAMEA HIV Therapy Drug Sales by Application (2027-2032) & (K Units) Table 284. SAMEA HIV Therapy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 285. SAMEA HIV Therapy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 286. SAMEA HIV Therapy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 287. SAMEA HIV Therapy Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 288. SAMEA HIV Therapy Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 289. SAMEA HIV Therapy Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 290. SAMEA HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 291. SAMEA HIV Therapy Drug Sales by Country (2027-2032) & (K Units) Table 292. SAMEA HIV Therapy Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 293. SAMEA HIV Therapy Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 294. Brazil HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 295. Argentina HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 296. Chile HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 297. Colombia HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 298. Peru HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 299. Saudi Arabia HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 300. Israel HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 301. UAE HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 302. Turkey HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 303. Iran HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 304. Egypt HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Table 305. Key Raw Materials Table 306. Raw Materials Key Suppliers Table 307. HIV Therapy Drug Distributors List Table 308. HIV Therapy Drug Customers List Table 309. Research Programs/Design for This Report Table 310. Authors List of This Report Table 311. Secondary Sources Table 312. Primary Sources List of Figures Figure 1. HIV Therapy Drug Image Figure 2. Global HIV Therapy Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HIV Therapy Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hiv Integrated Enzyme Chain Transfer Inhibitor Image Figure 5. Multi-Type Combined Drugs Image Figure 6. Non-Nucleoside Reverse Transcription Enzyme Inhibitors Image Figure 7. Nucleoside Reverse Transcription Enzyme Inhibitors Image Figure 8. Global HIV Therapy Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global HIV Therapy Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Pharmacy Image Figure 13. Global HIV Therapy Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global HIV Therapy Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global HIV Therapy Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global HIV Therapy Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global HIV Therapy Drug Revenue Market Share by Region (2021-2032) Figure 18. Global HIV Therapy Drug Sales (2021-2032) & (K Units) Figure 19. Global HIV Therapy Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global HIV Therapy Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico HIV Therapy Drug Sales YoY (2021-2032) & (K Units) Figure 22. Europe HIV Therapy Drug Sales YoY (2021-2032) & (K Units) Figure 23. China HIV Therapy Drug Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) HIV Therapy Drug Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa HIV Therapy Drug Sales YoY (2021-2032) & (K Units) Figure 26. Global HIV Therapy Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global HIV Therapy Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global HIV Therapy Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global HIV Therapy Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global HIV Therapy Drug Revenue Market Share by Type (2021-2032) Figure 32. Global HIV Therapy Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global HIV Therapy Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global HIV Therapy Drug Sales Market Share by Type (2021-2032) Figure 35. Global HIV Therapy Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global HIV Therapy Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global HIV Therapy Drug Revenue Market Share by Application (2021-2032) Figure 38. Global HIV Therapy Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global HIV Therapy Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global HIV Therapy Drug Sales Market Share by Application (2021-2032) Figure 41. North America HIV Therapy Drug Revenue Share by Type (2021-2032) Figure 42. North America HIV Therapy Drug Sales Share by Type (2021-2032) Figure 43. North America HIV Therapy Drug Revenue Share by Application (2021-2032) Figure 44. North America HIV Therapy Drug Sales Share by Application (2021-2032) Figure 45. North America HIV Therapy Drug Revenue Share by Country (2021-2032) Figure 46. North America HIV Therapy Drug Sales Share by Country (2021-2032) Figure 47. Europe HIV Therapy Drug Revenue Share by Type (2021-2032) Figure 48. Europe HIV Therapy Drug Sales Share by Type (2021-2032) Figure 49. Europe HIV Therapy Drug Revenue Share by Application (2021-2032) Figure 50. Europe HIV Therapy Drug Sales Share by Application (2021-2032) Figure 51. Europe HIV Therapy Drug Revenue Share by Country (2021-2032) Figure 52. Europe HIV Therapy Drug Sales Share by Country (2021-2032) Figure 53. China HIV Therapy Drug Revenue Share by Type (2021-2032) Figure 54. China HIV Therapy Drug Sales Share by Type (2021-2032) Figure 55. China HIV Therapy Drug Revenue Share by Application (2021-2032) Figure 56. China HIV Therapy Drug Sales Share by Application (2021-2032) Figure 57. Asia HIV Therapy Drug Revenue Share by Type (2021-2032) Figure 58. Asia HIV Therapy Drug Sales Share by Type (2021-2032) Figure 59. Asia HIV Therapy Drug Revenue Share by Application (2021-2032) Figure 60. Asia HIV Therapy Drug Sales Share by Application (2021-2032) Figure 61. Asia HIV Therapy Drug Revenue Share by Country (2021-2032) Figure 62. Asia HIV Therapy Drug Sales Share by Country (2021-2032) Figure 63. SAMEA HIV Therapy Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA HIV Therapy Drug Sales Share by Type (2021-2032) Figure 65. SAMEA HIV Therapy Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA HIV Therapy Drug Sales Share by Application (2021-2032) Figure 67. SAMEA HIV Therapy Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA HIV Therapy Drug Sales Share by Country (2021-2032) Figure 69. HIV Therapy Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. HIV Therapy Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Hiv Integrated Enzyme Chain Transfer Inhibitor
  • Multi-Type Combined Drugs
  • Non-Nucleoside Reverse Transcription Enzyme Inhibitors
  • Nucleoside Reverse Transcription Enzyme Inhibitors
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • AbbVie Inc.
  • Affine Formulations Limited
  • Beacon Pharmaceuticals
  • Biocon Limited
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Company
  • Cipla
  • Frontier Biotechnologies
  • Genentech, Inc.
  • Gilead Sciences, Inc
  • IPCA Laboratories
  • Janssen Pharmaceuticals, Inc.
  • Julphar Bangladesh
  • Merck & Co
  • MSD
  • Mylan Pharmaceuticals Inc.
  • Natco Pharma
  • Roche Holding AG
  • Shionogi
  • Theratechnologies Inc.
  • ViiV Healthcare
  • GSK
  • Pfizer
  • Johnson & Johnson
  • Teva Pharmaceuticals
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HIV Therapy Drug Market by Type
  3. 1.2.1 Global HIV Therapy Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hiv Integrated Enzyme Chain Transfer Inhibitor
  5. 1.2.3 Multi-Type Combined Drugs
  6. 1.2.4 Non-Nucleoside Reverse Transcription Enzyme Inhibitors
  7. 1.2.5 Nucleoside Reverse Transcription Enzyme Inhibitors
  8. 1.3 HIV Therapy Drug Market by Application
  9. 1.3.1 Global HIV Therapy Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Pharmacy
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 HIV Therapy Drug Market Dynamics
  1. 2.1 HIV Therapy Drug Industry Trends
  2. 2.2 HIV Therapy Drug Industry Drivers
  3. 2.3 HIV Therapy Drug Industry Opportunities and Challenges
  4. 2.4 HIV Therapy Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global HIV Therapy Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global HIV Therapy Drug Revenue by Region
  3. 3.2.1 Global HIV Therapy Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HIV Therapy Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global HIV Therapy Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global HIV Therapy Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global HIV Therapy Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global HIV Therapy Drug Sales by Region
  9. 3.4.1 Global HIV Therapy Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global HIV Therapy Drug Sales by Region (2021-2026)
  11. 3.4.3 Global HIV Therapy Drug Sales by Region (2027-2032)
  12. 3.4.4 Global HIV Therapy Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global HIV Therapy Drug Revenue by Manufacturers
  2. 4.1.1 Global HIV Therapy Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global HIV Therapy Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global HIV Therapy Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HIV Therapy Drug Sales by Manufacturers
  6. 4.2.1 Global HIV Therapy Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global HIV Therapy Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global HIV Therapy Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global HIV Therapy Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global HIV Therapy Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global HIV Therapy Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global HIV Therapy Drug Manufacturers, Product Type & Application
  13. 4.7 Global HIV Therapy Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global HIV Therapy Drug Market CR5 and HHI
  16. 4.8.2 2025 HIV Therapy Drug Tier 1, Tier 2, and Tier 3
5 HIV Therapy Drug Market by Type
  1. 5.1 Global HIV Therapy Drug Revenue by Type
  2. 5.1.1 Global HIV Therapy Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global HIV Therapy Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global HIV Therapy Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global HIV Therapy Drug Sales by Type
  6. 5.2.1 Global HIV Therapy Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global HIV Therapy Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global HIV Therapy Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global HIV Therapy Drug Price by Type
6 HIV Therapy Drug Market by Application
  1. 6.1 Global HIV Therapy Drug Revenue by Application
  2. 6.1.1 Global HIV Therapy Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global HIV Therapy Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global HIV Therapy Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global HIV Therapy Drug Sales by Application
  6. 6.2.1 Global HIV Therapy Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global HIV Therapy Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global HIV Therapy Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global HIV Therapy Drug Price by Application
7 Company Profiles
  1. 7.1 AbbVie Inc.
  2. 7.1.1 AbbVie Inc. Company Information
  3. 7.1.2 AbbVie Inc. Business Overview
  4. 7.1.3 AbbVie Inc. HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AbbVie Inc. HIV Therapy Drug Product Portfolio
  6. 7.1.5 AbbVie Inc. Recent Developments
  7. 7.2 Affine Formulations Limited
  8. 7.2.1 Affine Formulations Limited Company Information
  9. 7.2.2 Affine Formulations Limited Business Overview
  10. 7.2.3 Affine Formulations Limited HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Affine Formulations Limited HIV Therapy Drug Product Portfolio
  12. 7.2.5 Affine Formulations Limited Recent Developments
  13. 7.3 Beacon Pharmaceuticals
  14. 7.3.1 Beacon Pharmaceuticals Company Information
  15. 7.3.2 Beacon Pharmaceuticals Business Overview
  16. 7.3.3 Beacon Pharmaceuticals HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Beacon Pharmaceuticals HIV Therapy Drug Product Portfolio
  18. 7.3.5 Beacon Pharmaceuticals Recent Developments
  19. 7.4 Biocon Limited
  20. 7.4.1 Biocon Limited Company Information
  21. 7.4.2 Biocon Limited Business Overview
  22. 7.4.3 Biocon Limited HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biocon Limited HIV Therapy Drug Product Portfolio
  24. 7.4.5 Biocon Limited Recent Developments
  25. 7.5 Boehringer Ingelheim
  26. 7.5.1 Boehringer Ingelheim Company Information
  27. 7.5.2 Boehringer Ingelheim Business Overview
  28. 7.5.3 Boehringer Ingelheim HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Boehringer Ingelheim HIV Therapy Drug Product Portfolio
  30. 7.5.5 Boehringer Ingelheim Recent Developments
  31. 7.6 Bristol-Myers Squibb Company
  32. 7.6.1 Bristol-Myers Squibb Company Company Information
  33. 7.6.2 Bristol-Myers Squibb Company Business Overview
  34. 7.6.3 Bristol-Myers Squibb Company HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bristol-Myers Squibb Company HIV Therapy Drug Product Portfolio
  36. 7.6.5 Bristol-Myers Squibb Company Recent Developments
  37. 7.7 Cipla
  38. 7.7.1 Cipla Company Information
  39. 7.7.2 Cipla Business Overview
  40. 7.7.3 Cipla HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cipla HIV Therapy Drug Product Portfolio
  42. 7.7.5 Cipla Recent Developments
  43. 7.8 Frontier Biotechnologies
  44. 7.8.1 Frontier Biotechnologies Company Information
  45. 7.8.2 Frontier Biotechnologies Business Overview
  46. 7.8.3 Frontier Biotechnologies HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Frontier Biotechnologies HIV Therapy Drug Product Portfolio
  48. 7.8.5 Frontier Biotechnologies Recent Developments
  49. 7.9 Genentech, Inc.
  50. 7.9.1 Genentech, Inc. Company Information
  51. 7.9.2 Genentech, Inc. Business Overview
  52. 7.9.3 Genentech, Inc. HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Genentech, Inc. HIV Therapy Drug Product Portfolio
  54. 7.9.5 Genentech, Inc. Recent Developments
  55. 7.10 Gilead Sciences, Inc
  56. 7.10.1 Gilead Sciences, Inc Company Information
  57. 7.10.2 Gilead Sciences, Inc Business Overview
  58. 7.10.3 Gilead Sciences, Inc HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Gilead Sciences, Inc HIV Therapy Drug Product Portfolio
  60. 7.10.5 Gilead Sciences, Inc Recent Developments
  61. 7.11 IPCA Laboratories
  62. 7.11.1 IPCA Laboratories Company Information
  63. 7.11.2 IPCA Laboratories Business Overview
  64. 7.11.3 IPCA Laboratories HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 IPCA Laboratories HIV Therapy Drug Product Portfolio
  66. 7.11.5 IPCA Laboratories Recent Developments
  67. 7.12 Janssen Pharmaceuticals, Inc.
  68. 7.12.1 Janssen Pharmaceuticals, Inc. Company Information
  69. 7.12.2 Janssen Pharmaceuticals, Inc. Business Overview
  70. 7.12.3 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product Portfolio
  72. 7.12.5 Janssen Pharmaceuticals, Inc. Recent Developments
  73. 7.13 Julphar Bangladesh
  74. 7.13.1 Julphar Bangladesh Company Information
  75. 7.13.2 Julphar Bangladesh Business Overview
  76. 7.13.3 Julphar Bangladesh HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Julphar Bangladesh HIV Therapy Drug Product Portfolio
  78. 7.13.5 Julphar Bangladesh Recent Developments
  79. 7.14 Merck & Co
  80. 7.14.1 Merck & Co Company Information
  81. 7.14.2 Merck & Co Business Overview
  82. 7.14.3 Merck & Co HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Merck & Co HIV Therapy Drug Product Portfolio
  84. 7.14.5 Merck & Co Recent Developments
  85. 7.15 MSD
  86. 7.15.1 MSD Company Information
  87. 7.15.2 MSD Business Overview
  88. 7.15.3 MSD HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 MSD HIV Therapy Drug Product Portfolio
  90. 7.15.5 MSD Recent Developments
  91. 7.16 Mylan Pharmaceuticals Inc.
  92. 7.16.1 Mylan Pharmaceuticals Inc. Company Information
  93. 7.16.2 Mylan Pharmaceuticals Inc. Business Overview
  94. 7.16.3 Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Mylan Pharmaceuticals Inc. HIV Therapy Drug Product Portfolio
  96. 7.16.5 Mylan Pharmaceuticals Inc. Recent Developments
  97. 7.17 Natco Pharma
  98. 7.17.1 Natco Pharma Company Information
  99. 7.17.2 Natco Pharma Business Overview
  100. 7.17.3 Natco Pharma HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Natco Pharma HIV Therapy Drug Product Portfolio
  102. 7.17.5 Natco Pharma Recent Developments
  103. 7.18 Roche Holding AG
  104. 7.18.1 Roche Holding AG Company Information
  105. 7.18.2 Roche Holding AG Business Overview
  106. 7.18.3 Roche Holding AG HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Roche Holding AG HIV Therapy Drug Product Portfolio
  108. 7.18.5 Roche Holding AG Recent Developments
  109. 7.19 Shionogi
  110. 7.19.1 Shionogi Company Information
  111. 7.19.2 Shionogi Business Overview
  112. 7.19.3 Shionogi HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Shionogi HIV Therapy Drug Product Portfolio
  114. 7.19.5 Shionogi Recent Developments
  115. 7.20 Theratechnologies Inc.
  116. 7.20.1 Theratechnologies Inc. Company Information
  117. 7.20.2 Theratechnologies Inc. Business Overview
  118. 7.20.3 Theratechnologies Inc. HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Theratechnologies Inc. HIV Therapy Drug Product Portfolio
  120. 7.20.5 Theratechnologies Inc. Recent Developments
  121. 7.21 ViiV Healthcare
  122. 7.21.1 ViiV Healthcare Company Information
  123. 7.21.2 ViiV Healthcare Business Overview
  124. 7.21.3 ViiV Healthcare HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 ViiV Healthcare HIV Therapy Drug Product Portfolio
  126. 7.21.5 ViiV Healthcare Recent Developments
  127. 7.22 GSK
  128. 7.22.1 GSK Company Information
  129. 7.22.2 GSK Business Overview
  130. 7.22.3 GSK HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 GSK HIV Therapy Drug Product Portfolio
  132. 7.22.5 GSK Recent Developments
  133. 7.23 Pfizer
  134. 7.23.1 Pfizer Company Information
  135. 7.23.2 Pfizer Business Overview
  136. 7.23.3 Pfizer HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Pfizer HIV Therapy Drug Product Portfolio
  138. 7.23.5 Pfizer Recent Developments
  139. 7.24 Johnson & Johnson
  140. 7.24.1 Johnson & Johnson Company Information
  141. 7.24.2 Johnson & Johnson Business Overview
  142. 7.24.3 Johnson & Johnson HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Johnson & Johnson HIV Therapy Drug Product Portfolio
  144. 7.24.5 Johnson & Johnson Recent Developments
  145. 7.25 Teva Pharmaceuticals
  146. 7.25.1 Teva Pharmaceuticals Company Information
  147. 7.25.2 Teva Pharmaceuticals Business Overview
  148. 7.25.3 Teva Pharmaceuticals HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Teva Pharmaceuticals HIV Therapy Drug Product Portfolio
  150. 7.25.5 Teva Pharmaceuticals Recent Developments
  151. 7.26 Abbott
  152. 7.26.1 Abbott Company Information
  153. 7.26.2 Abbott Business Overview
  154. 7.26.3 Abbott HIV Therapy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Abbott HIV Therapy Drug Product Portfolio
  156. 7.26.5 Abbott Recent Developments
8 North America
  1. 8.1 North America HIV Therapy Drug Market Size by Type
  2. 8.1.1 North America HIV Therapy Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America HIV Therapy Drug Sales by Type (2021-2032)
  4. 8.1.3 North America HIV Therapy Drug Price by Type (2021-2032)
  5. 8.2 North America HIV Therapy Drug Market Size by Application
  6. 8.2.1 North America HIV Therapy Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America HIV Therapy Drug Sales by Application (2021-2032)
  8. 8.2.3 North America HIV Therapy Drug Price by Application (2021-2032)
  9. 8.3 North America HIV Therapy Drug Market Size by Country
  10. 8.3.1 North America HIV Therapy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America HIV Therapy Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America HIV Therapy Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe HIV Therapy Drug Market Size by Type
  2. 9.1.1 Europe HIV Therapy Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe HIV Therapy Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe HIV Therapy Drug Price by Type (2021-2032)
  5. 9.2 Europe HIV Therapy Drug Market Size by Application
  6. 9.2.1 Europe HIV Therapy Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe HIV Therapy Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe HIV Therapy Drug Price by Application (2021-2032)
  9. 9.3 Europe HIV Therapy Drug Market Size by Country
  10. 9.3.1 Europe HIV Therapy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe HIV Therapy Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe HIV Therapy Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China HIV Therapy Drug Market Size by Type
  2. 10.1.1 China HIV Therapy Drug Revenue by Type (2021-2032)
  3. 10.1.2 China HIV Therapy Drug Sales by Type (2021-2032)
  4. 10.1.3 China HIV Therapy Drug Price by Type (2021-2032)
  5. 10.2 China HIV Therapy Drug Market Size by Application
  6. 10.2.1 China HIV Therapy Drug Revenue by Application (2021-2032)
  7. 10.2.2 China HIV Therapy Drug Sales by Application (2021-2032)
  8. 10.2.3 China HIV Therapy Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HIV Therapy Drug Market Size by Type
  2. 11.1.1 Asia HIV Therapy Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia HIV Therapy Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia HIV Therapy Drug Price by Type (2021-2032)
  5. 11.2 Asia HIV Therapy Drug Market Size by Application
  6. 11.2.1 Asia HIV Therapy Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia HIV Therapy Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia HIV Therapy Drug Price by Application (2021-2032)
  9. 11.3 Asia HIV Therapy Drug Market Size by Country
  10. 11.3.1 Asia HIV Therapy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia HIV Therapy Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia HIV Therapy Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HIV Therapy Drug Market Size by Type
  2. 12.1.1 SAMEA HIV Therapy Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA HIV Therapy Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA HIV Therapy Drug Price by Type (2021-2032)
  5. 12.2 SAMEA HIV Therapy Drug Market Size by Application
  6. 12.2.1 SAMEA HIV Therapy Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA HIV Therapy Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA HIV Therapy Drug Price by Application (2021-2032)
  9. 12.3 SAMEA HIV Therapy Drug Market Size by Country
  10. 12.3.1 SAMEA HIV Therapy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA HIV Therapy Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA HIV Therapy Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 HIV Therapy Drug Value Chain Analysis
  2. 13.1.1 HIV Therapy Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 HIV Therapy Drug Production Mode & Process
  6. 13.2 HIV Therapy Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 HIV Therapy Drug Distributors
  9. 13.2.3 HIV Therapy Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst